Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

PRPH

ProPhase Labs (PRPH)

ProPhase Labs Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:PRPH
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRPHProPhase Labs Inc
09/05/202416:08Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PRPHProPhase Labs Inc
09/05/202414:40GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - UpdatedNASDAQ:PRPHProPhase Labs Inc
09/05/202407:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRPHProPhase Labs Inc
09/05/202407:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.NASDAQ:PRPHProPhase Labs Inc
02/05/202407:00GlobeNewswire Inc.PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9NASDAQ:PRPHProPhase Labs Inc
25/04/202407:00GlobeNewswire Inc.ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024NASDAQ:PRPHProPhase Labs Inc
16/04/202407:00GlobeNewswire Inc.ProPhase Labs Unveils Project ZenQ-AINASDAQ:PRPHProPhase Labs Inc
10/04/202407:00GlobeNewswire Inc.ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024NASDAQ:PRPHProPhase Labs Inc
01/04/202420:00GlobeNewswire Inc.ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PRPHProPhase Labs Inc
15/03/202407:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic InitiativesNASDAQ:PRPHProPhase Labs Inc
08/03/202407:00GlobeNewswire Inc.PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024NASDAQ:PRPHProPhase Labs Inc
20/02/202407:00GlobeNewswire Inc.ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMARTNASDAQ:PRPHProPhase Labs Inc
14/02/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRPHProPhase Labs Inc
14/02/202407:00GlobeNewswire Inc.ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement EquivirNASDAQ:PRPHProPhase Labs Inc
30/01/202407:00GlobeNewswire Inc.ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula GenomicsNASDAQ:PRPHProPhase Labs Inc
23/01/202407:00GlobeNewswire Inc.Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New ContractsNASDAQ:PRPHProPhase Labs Inc
04/01/202407:00GlobeNewswire Inc.ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024NASDAQ:PRPHProPhase Labs Inc
09/11/202307:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023NASDAQ:PRPHProPhase Labs Inc
02/11/202307:00GlobeNewswire Inc.ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern TimeNASDAQ:PRPHProPhase Labs Inc
17/10/202307:00GlobeNewswire Inc.ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.NASDAQ:PRPHProPhase Labs Inc
12/10/202307:25GlobeNewswire Inc.DSS Inc. Issues Letter to ShareholdersNASDAQ:PRPHProPhase Labs Inc
12/10/202307:00GlobeNewswire Inc.ProPhase Labs to Present at The ThinkEquity ConferenceNASDAQ:PRPHProPhase Labs Inc
10/08/202309:40GlobeNewswire Inc.ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.NASDAQ:PRPHProPhase Labs Inc
10/08/202307:00GlobeNewswire Inc.ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023NASDAQ:PRPHProPhase Labs Inc
03/08/202307:00GlobeNewswire Inc.ProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker CompoundNASDAQ:PRPHProPhase Labs Inc
02/08/202307:00GlobeNewswire Inc.ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern TimeNASDAQ:PRPHProPhase Labs Inc
29/06/202307:05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRPHProPhase Labs Inc
29/06/202307:00GlobeNewswire Inc.Navidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of NavideaNASDAQ:PRPHProPhase Labs Inc
22/06/202307:30GlobeNewswire Inc.ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics TechnologiesNASDAQ:PRPHProPhase Labs Inc
 Showing the most relevant articles for your search:NASDAQ:PRPH

Su Consulta Reciente